![PDF) Case report of successful low-dose, ultra-slow infusion thrombolysis of prosthetic mitral valve thrombosis in a high risk patient after redo-mitral valve replacement PDF) Case report of successful low-dose, ultra-slow infusion thrombolysis of prosthetic mitral valve thrombosis in a high risk patient after redo-mitral valve replacement](https://i1.rgstatic.net/publication/339962826_Case_report_of_successful_low-dose_ultra-slow_infusion_thrombolysis_of_prosthetic_mitral_valve_thrombosis_in_a_high_risk_patient_after_redo-mitral_valve_replacement/links/5e701f0c458515eb5aba79f5/largepreview.png)
PDF) Case report of successful low-dose, ultra-slow infusion thrombolysis of prosthetic mitral valve thrombosis in a high risk patient after redo-mitral valve replacement
Ioannis P. Capos (Kapos) on LinkedIn: BD, CerTest Biotec Announce Emergency Use Authorization for Mpox…
![Robert Manka on X: "Join the Journal Club on #LGE Malgorzata Polacin will present our latest work on short LGE for a better virtualization of infarct scars @Unispital_USZ #WhyCMR @SCMRorg @Doc_Tiger" / Robert Manka on X: "Join the Journal Club on #LGE Malgorzata Polacin will present our latest work on short LGE for a better virtualization of infarct scars @Unispital_USZ #WhyCMR @SCMRorg @Doc_Tiger" /](https://pbs.twimg.com/media/El_KZpIXUAA_1tK.jpg)